{"id":7910,"date":"2024-12-18T19:08:58","date_gmt":"2024-12-18T11:08:58","guid":{"rendered":"https:\/\/regask.com\/?p=7910"},"modified":"2024-12-18T19:08:58","modified_gmt":"2024-12-18T11:08:58","slug":"guia-de-dispositivos-de-inteligencia-artificial-de-la-fda-pccp","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/fda-ai-device-guidance-pccp\/","title":{"rendered":"La FDA (EE. UU.) publica una gu\u00eda final sobre el cambio predeterminado\u2026"},"content":{"rendered":"<p>El 4 de diciembre de 2024, la Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos (FDA) emiti\u00f3 su gu\u00eda final, <strong>\u201cRecomendaciones de presentaci\u00f3n de marketing para un plan de control de cambios predeterminado para funciones de software de dispositivos habilitados para inteligencia artificial\u201d.<\/strong> Esta actualizaci\u00f3n representa un avance clave en el <a href=\"https:\/\/regask.com\/es\/guia-de-la-fda-sobre-dispositivos-medicos-contra-el-covid-19\/\">Marco regulatorio de la FDA<\/a>, dise\u00f1ado para respaldar la innovaci\u00f3n continua en dispositivos m\u00e9dicos habilitados con IA, manteniendo al mismo tiempo su seguridad y eficacia.<\/p>\n<p>La gu\u00eda introduce el concepto de <strong>Plan de control de cambios predeterminado (PCCP)<\/strong>, que detalla las modificaciones planificadas para los dispositivos habilitados con IA. El PCCP incluye metodolog\u00edas para el desarrollo, la validaci\u00f3n y la implementaci\u00f3n de estos cambios, as\u00ed como evaluaciones de su impacto en la seguridad y la eficacia del dispositivo.<\/p>\n<p><strong>Puntos destacados:<\/strong><\/p>\n<ul>\n<li><strong>\u00c1mbito de aplicaci\u00f3n:<\/strong><br \/>\nLa gu\u00eda se aplica a dispositivos habilitados para IA en varias categor\u00edas de productos, incluidos aquellos revisados bajo las v\u00edas de notificaci\u00f3n previa a la comercializaci\u00f3n 510(k), solicitud de clasificaci\u00f3n De Novo y aprobaci\u00f3n previa a la comercializaci\u00f3n (PMA). Tambi\u00e9n abarca componentes de dispositivos de productos combinados dirigidos por dispositivos.<\/li>\n<li><strong>Proceso de revisi\u00f3n:<\/strong><br \/>\nLa FDA evaluar\u00e1 el PCCP como parte de la presentaci\u00f3n de la solicitud de comercializaci\u00f3n del dispositivo, asegur\u00e1ndose de que las modificaciones planificadas cumplan con los est\u00e1ndares de seguridad y eficacia. Esto elimina la necesidad de nuevas solicitudes de comercializaci\u00f3n para cada modificaci\u00f3n incluida en el PCCP.<\/li>\n<li><strong>Comentarios p\u00fablicos y actualizaciones:<\/strong><br \/>\nLas revisiones de la gu\u00eda reflejan los comentarios del p\u00fablico, incluidas las aclaraciones sobre el alcance, los requisitos de etiquetado, los procesos de implementaci\u00f3n bajo un PCCP autorizado y las recomendaciones de vigilancia posterior a la comercializaci\u00f3n. Se actualizaron las definiciones de &quot;inteligencia artificial&quot; y &quot;aprendizaje autom\u00e1tico&quot; para alinearse con <strong>Orden ejecutiva 14110<\/strong> emitida el 30 de octubre de 2023.<\/li>\n<\/ul>\n<p>Esta gu\u00eda marca un hito en las pr\u00e1cticas regulatorias para dispositivos habilitados para IA, equilibrando la innovaci\u00f3n con las prioridades de salud p\u00fablica.<\/p>\n<p>Para obtener m\u00e1s informaci\u00f3n o discutir estrategias de cumplimiento, comun\u00edquese con nosotros.<\/p>","protected":false},"excerpt":{"rendered":"<p>On December 4, 2024, the U.S. Food and Drug Administration (FDA) issued its final guidance, &#8220;Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions.&#8221; This update represents a key advancement in the FDA&#8217;s regulatory framework, designed to support continuous innovation in AI-enabled medical devices while maintaining their safety and&#8230;<\/p>","protected":false},"author":43,"featured_media":7925,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[527,39],"tags":[165,593,609,610,611],"class_list":["post-7910","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-united-states-regulations","category-medical-devices-insights","tag-public-health","tag-innovative-medical-devices","tag-guideline","tag-software-as-a-medical-device-samd","tag-ai-enabled-devices"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Finalizes Guidance on AI-Enabled Device Updates | RegASK<\/title>\n<meta name=\"description\" content=\"FDA issues final guidance on Predetermined Change Control Plans for AI-enabled devices. Read more at RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/guia-de-dispositivos-de-inteligencia-artificial-de-la-fda-pccp\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA (USA) Issues Final Guidance on Predetermined Change Control Plan for AI-Enabled Device Software\" \/>\n<meta property=\"og:description\" content=\"FDA issues final guidance on Predetermined Change Control Plans for AI-enabled devices. Read more at RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/guia-de-dispositivos-de-inteligencia-artificial-de-la-fda-pccp\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T11:08:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"FDA (USA) Issues Final Guidance on Predetermined Change&hellip;\",\"datePublished\":\"2024-12-18T11:08:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/\"},\"wordCount\":271,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png\",\"keywords\":[\"Public Health\",\"Innovative Medical Devices\",\"Guideline\",\"Software as a Medical Device (SaMD)\",\"AI-Enabled Devices\"],\"articleSection\":[\"United States\",\"Medical Devices\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/\",\"name\":\"FDA Finalizes Guidance on AI-Enabled Device Updates | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png\",\"datePublished\":\"2024-12-18T11:08:58+00:00\",\"description\":\"FDA issues final guidance on Predetermined Change Control Plans for AI-enabled devices. Read more at RegASK.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-ai-device-guidance-pccp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png\",\"width\":800,\"height\":600,\"caption\":\"Fda Usa Issues Final Guidance Predetermined Change Control Plan Ai Enabled Device Software\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FDA ultima las directrices sobre las actualizaciones de dispositivos habilitados para IA | RegASK","description":"La FDA publica una gu\u00eda final sobre los planes de control de cambios predeterminados para dispositivos habilitados con IA. Lea m\u00e1s en RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/guia-de-dispositivos-de-inteligencia-artificial-de-la-fda-pccp\/","og_locale":"es_ES","og_type":"article","og_title":"FDA (USA) Issues Final Guidance on Predetermined Change Control Plan for AI-Enabled Device Software","og_description":"FDA issues final guidance on Predetermined Change Control Plans for AI-enabled devices. Read more at RegASK.","og_url":"https:\/\/regask.com\/es\/guia-de-dispositivos-de-inteligencia-artificial-de-la-fda-pccp\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-12-18T11:08:58+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"FDA (USA) Issues Final Guidance on Predetermined Change&hellip;","datePublished":"2024-12-18T11:08:58+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/"},"wordCount":271,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png","keywords":["Public Health","Innovative Medical Devices","Guideline","Software as a Medical Device (SaMD)","AI-Enabled Devices"],"articleSection":["United States","Medical Devices"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/","url":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/","name":"La FDA ultima las directrices sobre las actualizaciones de dispositivos habilitados para IA | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png","datePublished":"2024-12-18T11:08:58+00:00","description":"La FDA publica una gu\u00eda final sobre los planes de control de cambios predeterminados para dispositivos habilitados con IA. Lea m\u00e1s en RegASK.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-ai-device-guidance-pccp\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/fda-ai-device-guidance-pccp\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/12\/fda-usa-issues-final-guidance-predetermined-change-control-plan-ai-enabled-device-software.png","width":800,"height":600,"caption":"Fda Usa Issues Final Guidance Predetermined Change Control Plan Ai Enabled Device Software"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plataforma de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con IA para ciencias de la vida y productos de consumo. RegASK combina modelos de negocio verticales, arquitectura de IA multiagente y una comunidad global de m\u00e1s de 1800 expertos para ofrecer an\u00e1lisis de horizontes regulatorios, an\u00e1lisis de impacto, automatizaci\u00f3n de flujos de trabajo de cumplimiento y resultados listos para auditor\u00edas en m\u00e1s de 160 pa\u00edses.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=7910"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7910\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/7925"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=7910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=7910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=7910"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}